Sunesis Pharmaceuticals, Inc. (SNSS) saw a big move last session, as the company’s shares fell by over 5% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for NVTL, as the stock is now up 19.7% since Feb 4.
This company in Biotechnology industry has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn’t changed either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
HBM currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same space include Actyelion Ltd. (ALIOF), Alexion Pharmaceuticals, Inc. (ALXN) and Biogen Idec Inc. (BIIB). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
SUNESIS PHARMACEUTICALS INC NEW (SNSS): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Investment & Company Information